Paper832019
Rate of reversal of hypercalcaemia and hypercalciuria induced by vitamin D and its 1alpha-hydroxylated derivatives.
Kanis JA and 1 other. Br Med J, 1977. Cited by 88 papers, by iCite.
Cite this record
ConductScience Library. Rate of reversal of hypercalcaemia and hypercalciuria induced by vitamin D and its 1alpha-hydroxylated derivatives. Papers, record 832019. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/832019
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Rate of reversal of hypercalcaemia and hypercalciuria induced by vitamin D and its 1alpha-hydroxylated derivatives.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Calcium | Major topic |
| Dihydrotachysterol | Major topic |
| Hydroxycholecalciferols | Major topic |
| Hypercalcemia | Major topic |
| Vitamin D | Major topic |
| Dihydroxycholecalciferols | |
| Humans | |
| Time Factors |
Source PubMed
References4
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 57505 | Variable response to long-term 1alpha-hydroxycholecalciferol in haemodialysis osteodystrophy. | Lancet | 1976 | https://conductscience.org/library/papers/57505 | PubMed |
| 2 | 4134407 | 1,25-dihydroxycholecalciferol and 1alpha-hydroxycholecalciferol in hypoparathyroidism. | Lancet | 1974 | https://conductscience.org/library/papers/4134407 | PubMed |
| 3 | 4131033 | Effects of 1,25-dihydroxycholecalciferol on calcium absorption, muscle weakness, and bone disease in chronic renal failure. | Lancet | 1974 | https://conductscience.org/library/papers/4131033 | PubMed |
| 4 | 170516 | Treatment of hypoparathyroidism and pseudohypoparathyroidism with metabolites of vitamin D: evidence for impaired conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D. | N Engl J Med | 1975 | https://conductscience.org/library/papers/170516 | PubMed |
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 88 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33133833 | From Psychiatry to Neurology and Endocrinology: A Case of Hypoparathyroidism. | Cureus | 2020 | https://conductscience.org/library/papers/33133833 | PubMed |
| 32738041 | Five-year Estimated Glomerular Filtration Rate in Patients With Hypoparathyroidism Treated With and Without rhPTH(1-84). | J Clin Endocrinol Metab | 2020 | https://conductscience.org/library/papers/32738041 | PubMed |
| 29694629 | Diagnosis and treatment of hypoparathyroidism: a position statement from the Brazilian Society of Endocrinology and Metabolism. | Arch Endocrinol Metab | 2018 | https://conductscience.org/library/papers/29694629 | PubMed |
| 29633734 | Current treatment of hypoparathyroidism: Theory versus reality waiting guidelines for children and adolescents. | Acta Biomed | 2018 | https://conductscience.org/library/papers/29633734 | PubMed |
| 28324108 | Hypoparathyroidism: Less Severe Hypocalcemia With Treatment With Vitamin D2 Compared With Calcitriol. | J Clin Endocrinol Metab | 2017 | https://conductscience.org/library/papers/28324108 | PubMed |
| 26938200 | Management of Hypoparathyroidism: Present and Future. | J Clin Endocrinol Metab | 2016 | https://conductscience.org/library/papers/26938200 | PubMed |
| 26318020 | Reversible vascular calcifications associated with hypervitaminosis D. | J Nephrol | 2016 | https://conductscience.org/library/papers/26318020 | PubMed |
| 22090268 | Synthetic human parathyroid hormone 1-34 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism. | J Clin Endocrinol Metab | 2012 | https://conductscience.org/library/papers/22090268 | PubMed |
| 21812031 | Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. | J Bone Miner Res | 2011 | https://conductscience.org/library/papers/21812031 | PubMed |
| 9536328 | Vitamin D and analogues in renal bone disease and implications for osteoporosis. | Osteoporos Int | 1997 | https://conductscience.org/library/papers/9536328 | PubMed |
| 9536320 | Treatment of osteoporosis with vitamin D. | Osteoporos Int | 1997 | https://conductscience.org/library/papers/9536320 | PubMed |
| 7429331 | Treatment of bone disease after jejunoileal bypass for obesity with oral 1 alpha-hydroxyvitamin D3. | Gut | 1980 | https://conductscience.org/library/papers/7429331 | PubMed |
| 7312738 | Hypercalcaemia in alphacalcidol therapy. | Postgrad Med J | 1981 | https://conductscience.org/library/papers/7312738 | PubMed |
| 7033299 | Osteomalacia and chronic renal failure. | J Clin Pathol | 1981 | https://conductscience.org/library/papers/7033299 | PubMed |
| 6489426 | Effect of bendrofluazide on calcium reabsorption in hypoparathyroidism. | Eur J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6489426 | PubMed |
| 6412828 | Renal handling of calcium in hypoparathyroidism. | Br Med J (Clin Res Ed) | 1983 | https://conductscience.org/library/papers/6412828 | PubMed |
| 6307498 | Studies on the mode of action of vitamin D XXXVII 1 alpha-hydroxyvitamin D3: a long-acting 1,25-dihydroxyvitamin D3 analog. | Calcif Tissue Int | 1983 | https://conductscience.org/library/papers/6307498 | PubMed |
| 6296868 | 1 alpha,25-Dihydroxyvitamin D3 and 1 alpha-hydroxyvitamin D3 prolong survival time of mice inoculated with myeloid leukemia cells. | Proc Natl Acad Sci U S A | 1983 | https://conductscience.org/library/papers/6296868 | PubMed |
| 6262039 | Pharmacology and therapeutic use of vitamin D and its analogues. | Drugs | 1981 | https://conductscience.org/library/papers/6262039 | PubMed |
| 6246841 | Treatment of hypophosphataemic vitamin D-resistant rickets with massive doses of 1 alpha-hydroxy-vitamin D3 during childhood. | Arch Dis Child | 1980 | https://conductscience.org/library/papers/6246841 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/832019
GET https://conductscience.org/api/papers/v1/832019/cited_by?page=2